Related Experiment Video

Updated: Aug 16, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Postmenopausal bleeding on hormone replacement therapy: review of the current referral guidelines

H Abouzeid1, P W Reginald

  • 1Heatherwood and Wexham Park NHS Trust, Berkshire, UK. amrwehana@aol.com

Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology
|September 9, 2005
PubMed

Insights

This study reassesses National Health Service (NHS) guidelines for postmenopausal bleeding (PMB) in patients using hormone replacement therapy (HRT). It aims to ensure current referral recommendations align with best practices for HRT patients experiencing PMB.

Area of Science:

  • Gynecology
  • Endocrinology

Background:

  • Postmenopausal bleeding (PMB) requires careful evaluation.
  • Hormone replacement therapy (HRT) is commonly used by postmenopausal women.
  • Current National Health Service (NHS) guidelines dictate referral protocols for PMB in HRT users.

Purpose of the Study:

  • To critically evaluate and reassess the existing NHS guidelines.
  • To determine the appropriate referral pathways for patients on HRT with PMB.
  • To ensure guidelines reflect current clinical understanding and patient safety.

Main Methods:

  • Review of current NHS guidelines on PMB and HRT.
  • Analysis of referral criteria within the guidelines.
  • Comparison with established clinical best practices (details not provided in abstract).

Main Results:

  • The study identified a need to reassess current NHS guidelines.
  • Specific areas for potential guideline revision were highlighted (details not provided in abstract).
  • The existing guidelines may require updates to optimize patient management.

Conclusions:

  • Reassessment of NHS guidelines for PMB in HRT patients is warranted.
  • Updated guidelines are crucial for appropriate patient referral and management.
  • Ensuring guideline relevance supports effective clinical decision-making for HRT users with PMB.

Related Concept Videos

Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...